🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/01/2009 27,58 28,25 27,15 27,41 -2,15% 4,01% 11.125.987
08/01/2009 28,32 28,33 27,71 28,02 -0,44% 2,19% 11.092.137
07/01/2009 28,25 28,51 27,82 28,14 -1,60% 2,43% 13.325.530
06/01/2009 29,66 29,83 28,20 28,60 -1,83% 5,50% 15.752.698
05/01/2009 30,01 30,21 28,90 29,13 -1,52% 4,36% 15.686.988
02/01/2009 29,06 29,69 28,92 29,58 +1,97% 2,66% 12.793.355
31/12/2008 28,34 29,17 28,33 29,01 +2,70% 2,96% 12.601.362
30/12/2008 27,35 28,30 27,35 28,24 +4,59% 3,49% 11.546.130
29/12/2008 27,78 27,91 26,67 27,00 -2,41% 4,47% 13.581.032
26/12/2008 28,05 28,15 27,43 27,67 -0,92% 2,55% 4.039.726
24/12/2008 28,02 28,30 27,77 27,93 -0,48% 1,91% 3.538.258
23/12/2008 28,02 28,84 27,85 28,06 +1,10% 3,51% 19.325.120
22/12/2008 27,17 28,03 26,99 27,76 +1,86% 3,83% 17.876.784
19/12/2008 26,77 27,74 26,38 27,25 +2,96% 5,06% 27.899.751
18/12/2008 26,14 27,03 25,82 26,47 +2,29% 4,64% 19.715.290
17/12/2008 25,94 26,56 25,70 25,88 -2,83% 3,31% 14.852.151
16/12/2008 25,81 26,81 25,27 26,63 +4,92% 5,99% 16.542.680
15/12/2008 25,72 25,99 25,00 25,38 -1,63% 3,86% 13.112.471
12/12/2008 24,71 25,91 24,64 25,80 +2,27% 5,14% 13.955.063
11/12/2008 25,57 26,50 25,00 25,23 -2,00% 5,86% 13.150.828
10/12/2008 25,20 26,15 25,20 25,74 +2,55% 3,79% 13.838.735
09/12/2008 26,11 26,20 24,96 25,11 -2,56% 4,75% 20.390.936
08/12/2008 25,77 26,41 25,52 25,76 +1,93% 3,44% 16.085.018
05/12/2008 23,54 25,69 23,02 25,28 +5,96% 11,31% 24.317.582
04/12/2008 24,17 24,84 23,49 23,86 -5,52% 5,57% 21.624.222
03/12/2008 24,48 25,47 24,27 25,25 -0,82% 4,91% 15.567.516
02/12/2008 24,69 25,54 24,20 25,46 +7,36% 5,45% 16.288.121
01/12/2008 25,16 25,52 23,63 23,71 -7,00% 7,55% 15.388.518
28/11/2008 24,50 25,50 24,47 25,50 +1,56% 4,21% 6.205.522
26/11/2008 24,24 25,18 23,86 25,11 +1,94% 5,47% 13.383.484